Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO - Get Free Report)'s share price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.26 and traded as low as $0.26. Northwest Biotherapeutics shares last traded at $0.26, with a volume of 2,168,789 shares.
Northwest Biotherapeutics Price Performance
The firm's fifty day moving average price is $0.26 and its two-hundred day moving average price is $0.26. The stock has a market cap of $376.82 million, a price-to-earnings ratio of -3.67 and a beta of -1.12.
Northwest Biotherapeutics (OTCMKTS:NWBO - Get Free Report) last released its earnings results on Thursday, May 15th. The biotechnology company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.38 million for the quarter.
Northwest Biotherapeutics Company Profile
(
Get Free Report)
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer.
Featured Stories
Before you consider Northwest Biotherapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Northwest Biotherapeutics wasn't on the list.
While Northwest Biotherapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
